Standard Biotools (LAB) Net Income towards Common Stockholders (2010 - 2026)
Standard Biotools (LAB) reported Net Income towards Common Stockholders of $141.7 million for Q1 2026, up 5420.84% year-over-year from $2.6 million in Q1 2025, and up 6632.69% on a QoQ basis from -$2.2 million in Q4 2025.
Standard Biotools (LAB) has 17 years of Net Income towards Common Stockholders data on file, last reported at $141.7 million in Q1 2026.
- Quarterly Net Income towards Common Stockholders rose 5420.84% year-over-year to $141.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $90.2 million (up 216.8% YoY) and the FY2025 annual result came in at -$74.9 million, up 45.31% from the prior year.
- Net Income towards Common Stockholders rose to $141.7 million in Q1 2026 per LAB's latest filing, from -$2.2 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $141.7 million in Q1 2026 and bottomed at -$76.3 million in Q1 2022.
- The 5-year median for Net Income towards Common Stockholders is -$21.0 million (2023), against an average of -$13.2 million.
- The widest annual swing landed in 2022, when Net Income towards Common Stockholders sank 305.82%; it then jumped 5420.84% in 2026.
- Tracing LAB's Net Income towards Common Stockholders over 5 years: stood at -$2.0 million in 2022, then jumped by 1156.13% to $20.7 million in 2023, then tumbled by 231.4% to -$27.2 million in 2024, then soared by 92.02% to -$2.2 million in 2025, then surged by 6632.69% to $141.7 million in 2026.
- Per Business Quant, the three latest LAB Net Income towards Common Stockholders figures stand at $141.7 million (Q1 2026), -$2.2 million (Q4 2025), and -$31.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 187,319.30 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Standard Biotools | 448.37 Mn | -6.80 Mn | 11.31 Mn | 141.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 141.69 Mn |
| Dec 31, 2025 | -2.17 Mn |
| Sep 30, 2025 | -31.68 Mn |
| Jun 30, 2025 | -17.67 Mn |
| Mar 31, 2025 | -2.66 Mn |
| Dec 31, 2024 | -27.17 Mn |
| Sep 30, 2024 | -21.92 Mn |
| Jun 30, 2024 | -25.44 Mn |
| Mar 31, 2024 | -32.16 Mn |
| Dec 31, 2023 | 20.68 Mn |
| Sep 30, 2023 | -21.05 Mn |
| Jun 30, 2023 | -17.04 Mn |
| Mar 31, 2023 | -16.88 Mn |
| Dec 31, 2022 | -1.96 Mn |
| Sep 30, 2022 | -29.44 Mn |
| Jun 30, 2022 | -63.55 Mn |
| Mar 31, 2022 | -76.26 Mn |
| Sep 30, 2021 | -13.84 Mn |
| Jun 30, 2021 | -17.16 Mn |
| Mar 31, 2021 | -18.79 Mn |
| Dec 31, 2020 | -18.03 Mn |
| Sep 30, 2020 | -6.00 Mn |
| Jun 30, 2020 | -13.02 Mn |
| Mar 31, 2020 | -15.98 Mn |
| Dec 31, 2019 | -12.69 Mn |
| Sep 30, 2019 | -12.89 Mn |
| Jun 30, 2019 | -13.75 Mn |
| Mar 31, 2019 | -25.47 Mn |
| Dec 31, 2018 | -14.81 Mn |
| Sep 30, 2018 | -14.75 Mn |
| Jun 30, 2018 | -16.24 Mn |
| Mar 31, 2018 | -13.25 Mn |
| Dec 31, 2017 | -10.41 Mn |
| Sep 30, 2017 | -15.94 Mn |
| Jun 30, 2017 | -16.96 Mn |
| Mar 31, 2017 | -17.18 Mn |
| Dec 31, 2016 | -17.70 Mn |
| Sep 30, 2016 | -19.80 Mn |
| Jun 30, 2016 | -18.62 Mn |
| Mar 31, 2016 | -19.88 Mn |
| Dec 31, 2015 | -12.88 Mn |
| Sep 30, 2015 | -9.27 Mn |
| Jun 30, 2015 | -15.24 Mn |
| Mar 31, 2015 | -15.93 Mn |
| Dec 31, 2014 | -10.94 Mn |
| Sep 30, 2014 | -13.79 Mn |
| Jun 30, 2014 | -12.68 Mn |
| Mar 31, 2014 | -15.41 Mn |
| Dec 31, 2013 | -4.64 Mn |
| Sep 30, 2013 | -4.29 Mn |
| Jun 30, 2013 | -4.05 Mn |
| Mar 31, 2013 | -3.55 Mn |
| Dec 31, 2012 | -3.60 Mn |
| Sep 30, 2012 | -4.15 Mn |
| Jun 30, 2012 | -4.58 Mn |
| Mar 31, 2012 | -6.69 Mn |
| Dec 31, 2011 | -3.46 Mn |
| Sep 30, 2011 | -4.49 Mn |
| Jun 30, 2011 | -7.19 Mn |
| Mar 31, 2011 | -17.24 Mn |
| Dec 31, 2010 | -3.08 Mn |
| Sep 30, 2010 | -3.38 Mn |
| Jun 30, 2010 | -4.82 Mn |